key: cord-0314299-gldsom4r authors: Sydney Smith, Jared D.; Megaro, Vanessa; Spejo, Aline Barroso; Moon, Lawrence D. F. title: An Adeno-Associated Viral vector encoding Neurotrophin 3 injected into affected forelimb muscles modestly improves sensorimotor function after contusive mid-cervical spinal cord injury date: 2021-02-25 journal: bioRxiv DOI: 10.1101/2021.02.24.432676 sha: 4b88ba1a59849fe4052ef52caefa462ae2cf4206 doc_id: 314299 cord_uid: gldsom4r Traumatic spinal cord injury (SCI) in humans occurs most frequently in the cervical spine where it can cause substantial sensorimotor impairments to upper limb function. The altered input to spinal circuits below the lesion leads to maladaptive reorganisation which often leads to hyperreflexia in proprioceptive circuits. Neurotrophin 3 (NT3) is growth factor essential for the development of proprioceptive neurons. We have previously shown that following bilateral corticospinal tract axotomy, intramuscular delivery of an Adeno-Associated Viral vector encoding NT3 (AAV-NT3) induces proprioceptive circuit reorganisation linked to functional recovery. To assess its therapeutic effects following a clinically relevant bilateral C5-C6 contusion in rats, AAV-NT3 was injected intramuscularly into the dominant limb 24 hours after injury and forelimb function was assessed over 13 weeks. The injury generated hyperreflexia of a distal forelimb proprioceptive circuit. There was also loss of fine motor skills during reach-and-grasp and walking on a horizontal ladder. Ex vivo magnetic resonance imaging (MRI) revealed atrophy of the spinal cord and white matter disruption throughout the lesion site together with extensive loss of grey matter. Unexpectedly, animals treated with AAV-NT3 had a slightly smaller lesion in the regions close to the epicentre compared to PBS treated animals. Rats treated with AAV-NT3 showed subtly better performance on the horizontal ladder and transient benefits on reach-and-grasp. AAV-NT3 did not normalise hyperreflexia in a treated muscle. The treatment increased the amount of NT3 in treated muscles but, unexpectedly, serum levels were only elevated in a small subset of animals. These results show that this dose and delivery of AAV-NT3 may generate subtle improvements in locomotion but additional treatments will be required to overcome the widespread sensorimotor deficits caused by contusion injury. Neuroplasticity drives spontaneous recovery after traumatic spinal cord injury Traumatic injury to the spinal cord causes axotomy and neuronal death leading to impaired transmission of signals through the lesion site. Damaged neurons have limited capacity to regenerate axons, and as a result the relatively intact spinal circuitry below the lesion is left with reduced or no direct descending control. Despite this it is common for some degree of spontaneous recovery to occur [1] [2] [3] . In response to reduced supraspinal input, the circuitry undergoes a programme of sprouting. This includes increases in afferent input onto motor and premotor neurons [4] [5] [6] and the formation of relay connections through sprouting of descending fibres that contact long propriospinal neurons running contralateral to the lesion 7, 8 . Additionally, spared descending axons which remained intact after injury are influenced by the new cellular environment and collateralise to the denervated grey matter 9, 10 . This reorganisation of the spared circuitry requires continual local proprioceptive afferent input from muscle spindles, the sense organ in the muscle responsible for detecting stretches within the muscle 11 . In mice which had proprioceptive neurons ablated, and therefore have abnormal Ia afferent input to the spinal cord, the spontaneous recovery often seen after lateral hemisection does not occur and functional benefits such as regaining plantar stepping and interlimb coordination are absent 6 . These studies highlight the importance of proprioceptive afferent input not only for contributing to spontaneous restoration of function following injury but also their role in maintaining this function after the initial recovery phase 6 . Maladaptive plasticity can create abnormally excitable reflexes Not all reorganisation within the spinal circuitry is beneficial. For those patients with some residual function the development of spasticity, which is thought to occur partly due to maladaptive plasticity, can hamper recovery and impact on post injury health 12 . Spasticity is an upper motor syndrome characterised traditionally as increased stretch reflexes which are velocity dependent 13 , which manifest clinically as increased muscle tone and exaggerated reflexes below the neurological level of injury. The syndrome is a chronic condition with symptoms beginning several months after the initial injury and is present in up to 75% of patients suffering symptoms one year after injury 14, 15 . Despite being only one component of the spasticity syndrome, hyperreflexia of the stretch reflex is a well-studied phenomenon in both patients and numerous preclinical models of CNS injury [16] [17] [18] . The stretch reflex arc acts to contract the stretching muscle and comprises muscle spindles, Ia afferents, the monosynaptic connection between Ia afferents and homonymous α-motor neuron, and finally the α-motor neuron itself which innervates the muscle at the motor end plate 19, 20 . In reality this muscle contraction is a combination of both monosynaptic and polysynaptic connections mediated via premotor neurons, that converge on the motor neuron. The Hoffman (H) reflex is an artificially induced counterpart whereby Ia afferents are stimulated electrically and the resultant compound EMG in a distal muscle is measured. This has the benefit of being minimally invasive and removes variation from muscle spindle activation. The proprioceptive reflex circuit is open to modulation from numerous sources such as inhibition from antagonistic muscles, Renshaw inhibition and effects of descending motor pathways 21, 22 . Under normal physiological conditions repeated firing of muscle spindles, such as during voluntary movement, causes a near full suppression of the reflex, termed rate dependent depression. This response is attenuated or lost in many SCI patients such that the reflex remains large 16, 23 . The exact mechanism by which spasticity and hyperreflexia develops is unknown. A recent study in shows that spared reticulospinal function is positively correlated with the presence of spasticity in SCI patients 24 . In animal models a number of anatomical and molecular changes associated with hyperreflexia have been reported; alteration in the chloride ion transporter KCC2 in motor neurons 25 , persistent inward currents driving increased motor neuron excitability 26 , increased excitatory input from Ia afferents 5, 27 and reduced inhibition on the circuitry 28 . Whilst the symptoms of spasticity are amenable to pharmacological agents like Baclofen, a centrally acting GABAB receptor agonist, or α-2 adrenoreceptor agonists like tizanidine, these agents are associated with numerous contraindications and side effects at higher doses 29 . Currently no treatment exist that correct the underlying pathology. NT3 is an attractive treatment option based on its role in muscle afferent development. The survival and differentiation of Ia afferent neurons during development is dependent on neurotrophin-3 (NT3). A pro-form is synthesised and cleaved into a mature 15kDa protein which has been shown to be constitutively secreted from cultured neurons, however the pro-form also has the capacity to be released [30] [31] [32] [33] . Either form is suspected of being secreted from muscle spindles where it acts as a guidance molecule for the incoming afferents. NT3 is essential for the correct wiring of Ia afferents: without it the axons fail to innervate the peripheral muscle spindle and/or fail to project deep into the ventral horn to reach their central targets 34 . Beyond development, NT3 regulates the strength of sensory-motor monosynaptic connections in both intact and axotomized stretch reflex arc circuits 35, 36 . Additionally, NT3 is suspected to play a role in the normal functioning of descending pathways involved in locomotion, such as the corticospinal tract 37 and serotonergic fibres 38 , which continue to express the high affinity receptor in adulthood. NT3 binds primarily to tropomyosin kinase receptor type C (TrkC), its high affinity receptor, however it has the capability to bind and signal through the other Trk receptors 39 . It can also signal through the promiscuous neurotrophin receptor p75, which is involved in generating both pro-survival and pro-apoptotic states 40 . Whilst NT3 levels significantly drop in the muscle beyond the postnatal period 41 , the expression of its receptor TrkC remains high in large diameter dorsal root ganglia (DRG) neurons 42, 43 indicating mature proprioceptive neurons remain receptive to NT3. Previous studies highlight NT3 as a potent inducer of neuronal plasticity following injury. After exposure to increased NT3 at the lesion site , CST axons which have been transected undergo increased axonal sprouting 44 . After unilateral pyramidotomy, the intact CST responds in a similar way in the presence of elevated (transgenic) NT3 in the lumbar cord with enhanced sprouting across the spinal midline towards the ipsilesional grey matter 45, 46 . An increased level of NT3 is known to improve hindlimb function after; retrograde transport of NT3-expressing vectors to motor neurons 47, 48 , direct delivery of NT3 to the lesion site through intraspinal gene therapy 49 , intrathecal injection 50 or via NT3 secreting fibroblasts 51 . Rostrally located fibres which are spared after a partial CST injury are also responsive to elevated NT3 52 . These functional effects could also be a result of NT3 exposure strengthening monosynaptic proprioceptive afferent connections within the ventral horn 35 . Additionally, endogenous levels of NT3 in the spinal cord can be raised following exercise in intact and spinally transected rodents [53] [54] [55] . Fewer studies have focussed around whether NT3 can improve function in the forelimb following SCI, with those performed finding differing effects depending on location of the injury and NT3 treatment. Overexpression of NT3 in the reticular nucleus, the origin of reticulospinal tract fibres did not enhance pellet reaching recovery above control treated animals 56 . Following CST injury in the brainstem, overexpression of NT3 in forelimb flexor muscles and raised serum levels were able to partially restore several sensorimotor forelimb tasks, which interestingly coincided with complete reduction in hyperreflexia 57 . Pretreatment of muscles four weeks prior to injury with an adeno-associated viral vector (AAV) encoding NT3 was able to partially overcome forelimb deficits caused by dorsal column transection at the cervical level 58 . A combined therapy of NT3 and the anti-inflammatory cytokine interleukin-10 loaded onto a biocompatible nerve bridge has recently been shown to convey functional benefits in the affected forelimb after cervical lateral hemisection 59 . Treatment was delivered at the time of injury and shows synergistic effects can be achieved when combining NT3 with a pro-regenerative cellular environment. Rationale for testing Intramuscular NT3 in a cervical contusion. To date no one has assessed the therapeutic effects of NT3 as a monotherapy after cervical contusion. For patients with the highest grade of SCI that impairs function in both upper and lower limbs, the restoration of useful hand function is their main priority, where it would allow for greater independence 60 . Hyperreflexia develops in the forelimb in rodents after a moderate mid cervical contusion injury (Sydney-Smith et al., unpublished observations). Here, we set out to test the hypothesis that neurotrophin 3 would normalise the deficits in sensorimotor function, exaggerated spinal cord reflexes and changes to spinal cord connectivity that follow from cervical SCI. To maintain clinical relevance, the mid cervical injury was used again to model the most frequent location of injury in humans. Subcutaneous delivery of NT3 protein has been proven safe and well tolerated in patients with other conditions 61 , and an AAV encoding NT3 gene therapy approach is the focus of an ongoing Phase I/IIa safety and efficacy trial for Charcot Marie Tooth 1a neuropathy (NCT03520751). Through the use of intramuscular viral delivery of NT3 in this study it was hoped to generate a continual elevation of NT3 within the muscles of the forelimb in addition to raised levels of in the circulation. The exact mechanism by which the intramuscularly overexpressed NT3 conveys a therapeutic effect after SCI is unknown. This pool of NT3 protein in the muscles is assumed to bind to proprioceptive afferents, which express TrkC, and be trafficked to the DRG where it can induce transcriptional changes and possibly alter the connectivity and function of these afferents 62, 63 . NT3 has the capacity to be retrogradely transported in motor neurons, providing an additional route to the proprioceptive circuitry 64 . As NT3 can cross the bloodnervous system barrier, any elevation in serum could have an effect along the neuraxis 46 . The DRG might be particularly amenable to therapeutic effects through raised serum NT3 due to its dense fenestrated vasculature 65, 66 . In summary, delivery within the muscle offers a clinically applicable delivery route whilst enabling it to be trafficked to different neuronal targets, and possibly act through both sensory and motor components of spinal circuits as well as systemically across the blood-CNS barrier. All animal procedures were conducted in accordance with the UK Home Office guidelines and the Animals (Scientific Procedures) Act of 1986. A total of 30 Lister Hooded rats (Charles River), weighing 240-270g were used at the start of the study, with five animals being excluded from the study prior to surgery due to poor reaching ability following training and a further three dying due to anaesthetic complications at varying stages of the study. Animals were group housed in standard conditions with a 12 hr light/dark cycle and access to chow food and water ad libitum. Animals were acclimatised in the unit for at least one week prior to any behavioural or surgical procedures but during this time animals were handled daily. To acclimatise them to the post injury recovery diet animals were offered high calorific food such as; peanut butter, chocolate spread and seeds, in addition to nutritional and hydration supplements (Dietgel #76A and Hydrogel, ClearH20) approximately one week prior to injury. The study was a stratified block design. Animals were ranked based on their final session of single pellet reaching during baseline sessions and allocated to 3 groups; contusion + NT3 (n=12), contusion + PBS (n=12) and uninjured + no treatment (n=5). This was achieved by allocating the best performer into the first treatment group, the next best into the second treatment group, the third best into the first treatment group and so forth. Every fifth animal was allocated as a naïve animal (Figure 1 ). This way each group would have an even spread of good and poorer performers on the pellet reaching task. Randomisation occurred at the level of the group: each contusion group was randomly allocated to receive either PBS or NT3. An independent person (Zoe Hore) coded the vial of AAV-NT3 and the vial of PBS as "J" or "S" so that all surgeons, observers, analysts and PI were blinded to treatment allocation. Blind-coded single-use aliquots were used and codes were only broken at the end of the experiment. Surgeries were performed during a single week starting with the poor pellet reaching performers and on each day there was an even spread of animals from both treatment groups. Because of this, animals were housed in mixed cages comprising injured animals of both NT3 and PBS treated animals. Naïve animals were housed together in a separate cage. The order of surgeries within a day was alternated, so that each day began with a different group (Figure 1 ). Each experimental animal had a Radio-frequency identification microchip inserted subcutaneously and this was used to identify each animal throughout the study. Blinding was broken once the ELISAs were performed; this occurred prior to horizontal ladder analysis but after all other behavioural and H reflex data was analysed. Only once the horizontal ladder data was assessed were the individual microchip numbers matched back up to the two treatment groups of 'J' or 'S', and then designated NT3 or PBS treated groups. performance. Animals were scored prior to injury, ranked from worst to best and sequentially allocated into one of two treatment groups. Every fifth animal was designated a naive animal. Surgeries began with the worst performers and on any single day there was an equal number from both treatment groups being operated and treated. S&J refer to the blinded treatments of either NT3 or PBS. N refers to naïve animals which did not undergo contusion injury or intramuscular injection. Rats were anaesthetised with Isoflurane, 5% for induction, reduced to 2% for maintenance during surgery, with oxygen flowing at 1L/min. Preoperatively 5mg/kg Enrofloxacin (Baytril) and 5 mg/kg carprofen (Carprieve) were injected subcutaneously. The region around the cervical and upper thoracic neck was shaved, the skin prepared with both 4% w/v chlorhexidine gluconate (Hibiscrub) and iodine antiseptic (Vetark Professionals). Finally, eye ointment (Viscotears) was applied. The animal was positioned prone on a homeothermic blanket (Harvard Apparatus), a rectal thermometer inserted to maintain a body temperature around 36°C. A 2 cm incision was made through the skin, from below the occiput to the T2 vertebral prominence to expose the underlying neck muscles. The hibernation gland and fat tissue between the scapulae were reflected caudally and the muscles overlaying the middle cervical vertebrae divided in separate layers. Using the spinous process of T2 as a landmark, and noting that rodents have seven cervical vertebrae, the lamina belonging to the C5 and C6 vertebrae were located and attached muscle removed. A bilateral laminectomy involving the entire C6 lamina and the caudal half of C5 was performed, exposing approximately 2mm either side of the midline. Loose cotton swabs were used to stop any bleeding and any sharp bone fragments within and around the laminectomy were carefully removed. The dura remained intact. The animal was transferred to the Infinite Horizons impactor (Precision Systems Instrumentation) and secured in place by two Addison forceps clamped on to the lateral processes of C5 and C7 vertebrae. A bilateral contusion, 225 kDyn with 0s dwell time was delivered using a 3mm diameter custom made tip (Precision Systems Instrumentation), corresponding to the region between the C6 and C7 spinal segments. Impact force and tissue displacement was recorded, and no impact produced a force/displacement curve suggestive of hitting bone or the animal slipping within the device. Sham animals (n=5) in this study did not received any surgery nor post-operative pain medication and are subsequently referred to as naives. The contusion site was inspected for bleeding and the muscles sutured in three layers using 4-0 Vicryl absorbable sutures (Ethicon). All animals received 5ml saline subcutaneously and placed in a 30°C water-based incubator (Thermocare) whilst the anaesthesia wore off. For at least the first four days after injury animals continued to receive; warm saline subcutaneously to combat dehydration, 5 mg/kg Baytril for potential bladder infection and 5mg/kg Carprieve for pain control. Rigid paralysis occurs in the forelimbs after injury and there is minimal hindlimb activity for the first few days post injury. During this time animals were laterally recumbent, which necessitated housing on soft paper bedding and being handfed high calorific food and water every few hours. Food and hydrogel were located around the cage and within reaching distance of their mouths. By one week after injury all animals regained the ability to weight-bear and reach food and were placed back onto sawdust in cages in the original holding rooms. Animals were able to void their bladders adequately and whilst bladder volume was checked during post-operative care, no manual expression was necessary. An AAV transfer plasmid, AAVspNT3, contained human prepro-Neurotrophin 3 under a CMV promoter. The neurotrophin-3 coding DNA sequence (NM_002527.4), corresponding to isoform 2 precursor protein including the secretory signal, was flanked by splice donor/splice acceptor sites and terminated in a beta globin poly(A) sequence, a gift of Prof. Fred Gage, Salk Institute. This was packaged into an adeno-associated viral vector serotype 1 by the University of Pennsylvania Viral Vector Core facility (custom batch CS1232). This viral vector is referred to in the text as AAV-NT3. The viral vector titre was measured by the Viral Vector Core using digital droplet PCR (6.2 x10 13 Genomic Copies (GC)/ml) and in our lab via qPCR (1.22 x10 13 GC/ml) by Dr Aline Spejo. The latter value was used for calculations when diluting AAV-NT3. Primers for the qPCR were: Forward 5'-AATTACCAGAGCACCCTGCC and Reverse 5'-TTTTGATCTCCCCCAGCACC. Twenty-four hours after the contusion surgery the muscles of the dominant forelimb, previously determined from single pellet reaching performance, were injected with a total of 1.04 x10 11 GC of AAV-NT3 diluted in 160 μl of PBS. Glass Hamilton syringes attached to a 26G metal needle with a non-coring bevel were used throughout with care taken to insert the needle bevel facing up and distal to the final injection site. Injections were either superficial, where the bevel of the needle was still visible through the fascia, or deep, where the bevel was no longer visible and resided in the remaining muscle bulk (Figure 1 ). Animals were anaesthetised with isoflurane and given eye ointment as before. Enrofloxacin and Carprieve was already given as part of the early morning post-operative care following the contusion injury, however an additional half dose (2.5mg/kg) of Carprieve was administered to animals that underwent intramuscular injections in the afternoon. The dominant forelimb was shaved and the skin and paw prepared as before. For all the muscle injections, the muscles were injected through the fascia and apart from the abductor digiti minimi (ADM), all muscle injections were made parallel to the bone. Following each set of muscle injections, the incision was sutured with 4-0 Vicryl sutures before moving onto the next. Muscle injections occurred in the following order: flexor compartment, extensor compartment, biceps brachii, triceps brachii and then ADM. For the forelimb flexors, the animal was positioned supine and the forearm was extended. A 1cm incision was made through the skin just below the elbow and the skin was retracted with blunted hook retractors. The flexor muscle compartment was injected via a series of six deep injections of 5ul each, running in a circumferential arc across the palpable fascial compartment. The needle was inserted close to the wrist and ran proximally whilst keeping parallel to the bone. The bevel was inserted two thirds of the distance proximodistally from wrist to the elbow before injecting. For forelimb extensors, the dominant forearm was supinated and taped above the animal's head. A similar incision was made as before on the radial side and skin was retracted. The extensor compartment was injected in a similar fashion with six deep injections of 5μl each in an arc approximately two thirds up for distal forearm. For Biceps Brachii, the arm was extended and supinated. A 1cm incision was made above the antecubital fossa and the skin was retracted. A total of three deep and three superficial injections, each 5 μl, was made, targeting approximately halfway between the insertion and origin of the biceps muscle. For Triceps Brachii the animal was positioned similarly for the extensor compartment and a slightly longer incision made from above the elbow proximally towards the shoulder. The skin was blunt-dissected and the long head of the triceps was exposed. This was injected with five deep injections of 5μl each and three superficial injections of 2.5μl each. The forearm was then further extended to expose the lateral head of the triceps from the same incision. This was injected with five deep injections of 5μl and three superficial injections of 2.5μl. Finally, the ADM muscle was injected through the paw skin with one deep and one superficial injection of 2.5μl each. Ability to successfully reach, grasp and return to eat 45mg pellets was assessed every two weeks in modified Whishaw window devices. Rats were placed in a Perspex cage with a 15 mm wide slit to allow for reaching. The sugar pellets were presented on a ledge 15 mm away from the reaching window and 5mm lateral from the edge of this window ( Figure 9A ). This gap limits grasping that uses compensatory reaching mechanisms such as dragging pellets. Animals were pretrained for several weeks prior to the study. Initially sugar pellets were positioned in the centre to facilitate learning and to determine the dominant paw. A sugar pellet was placed only once the animal's forepaw had both touched the ground and had repositioned. Animals were subsequently trained every other day for three weeks, with each session comprising 10 minutes of pellets being offered to the dominant paw. When scoring sessions, baseline or after injury, an initial ten pellets were given as a warm-up (which were not scored) followed by twenty pellets which were scored using the following definitions: 1. Success on first attempt -Animal retrieved and ate the pellet in a single continuous motion. 2. Success with multiple attempts -The animal retrieved and ate the pellet but took two or more attempts to do so. If the animal made five attempts and then retrieved the hand through the window the trial was recorded as a miss. This was rare as animals would usually knock the pellet off the ledge during the initial few attempts. 3. Miss-either the animal failed to reach the pellet within five attempts, or the pellet was knocked off the platform or it was dropped within the cage prior to being eaten. Baseline scores were averaged from two separate behaviour sessions. Owing to the low percentage of 'success on first attempt' being achieved at the end of training, animals were ranked according to percentage of 'Success with multiple attempts' before allocation into surgical groups. Ability to accurately place the forepaws during locomotion was assessed with the horizontal ladder every two weeks. Rats were filmed crossing a horizontal ladder with one metre of randomly spaced rungs ranging from 1-3cm apart. Each session, a total of three complete runs were filmed per rat and any run where the animal stopped for more than one second was discarded. Videos were analysed and steps on both forelimb sides assessed using seven point horizontal ladder scoring system 67 . Briefly, a score from zero to two indicated slip based errors; zero is a total miss where the forelimb did not contact the rung at all, one is a deep slip where the limb weight bears but slips causing disrupted locomotion and two indicated a slip similar to previously but without interruption to gait cycle. Scores of three to five represent placement errors; three indicates a step whereby the animal initially places the paw but then replaces it on another rung prior to weight bearing, four indicates the paw was either adjusted on the same rung or was repositioned to another rung prior to contact and finally five indicates steps where the wrist or a few digits weight supported the animal as the paw did not make full contact with the rung. A score of six indicates an error free step. The initial and final step were omitted from analysis and only steps that fell on the irregular spaced rungs were assessed. Grip strength was assessed every two weeks using a Dunnett Style Grip Strength Meter (Linton Instrumentation). This device comprises two collinear bars attached to separate force transducers and is capable of recording grip strength of each forelimb independently yet simultaneously. Rats were held around their hip and were lowered over the device until rats grabbed both bars with all forepaw digits. Steady but firm pressure was used to pull horizontally on the base of the rat's tail until it released its grip. Measurements were averaged over three trials taken within the same testing session. This task was performed last to avoid any negative effects from the stressful exertion on the performance in other tasks. Cholera Toxin Subunit B (#104, List Biologicals) was used to retrogradely trace motor neurons of the distal forearm three to four days prior to perfusion. Animals were anaesthetised and both arms prepared for surgery as before for muscle injections. An incision was made on the ulnar side of the distal forearm and then skin was retracted. The fascia covering the Flexor Digitorium Profundus and Flexor Carpi Ulnaris was cut and blunt dissection used to free up the ulnar nerve where it bifurcates distal to the elbow. Using a 34G needle on a Hamilton syringe, a total of 1μl of 1% Cholera Toxin B diluted in ddH20 was injected slowly into both ulnar fascicles. The fascia and skin were sutured. Animals did not appear to suffer any loss of function of the distal forearms due to the injections, however no behaviour was assessed after tracing. One animal from the NT3 group died during anaesthesia. gene, which when cleaved from their pro-domains, is identical to mature rat NT3. This means any endogenous NT3 is also detected by this assay. The lower limit of detection is 4.12 pg/ml. Whole blood was centrifuged at 10,000 rpm (8200 g) at room temperature, and the serum removed without agitating the clot. Serum was spun again for a further 5 mins, aliquoted and A moderate contusive injury of 225kdyn was delivered to 24 Lister Hooded rats between the C5 and C6 laminae, corresponding to the C6-C7 spinal level. Contused rats either received 1x10 11 GC of AAV-NT3 in 165μl PBS (termed NT3 group, n=12) or an equivalent volume of PBS (termed PBS group, n=12). Uninjured rats served as the injury control for this study and received no injury (termed naïve group, n=5). Starting one week after injury the degree of forelimb hyperreflexia was assessed every other week until the end of the study. Assessment of sensorimotor function took place at two weeks post injury and then every subsequent two weeks (Figure 2A ). At the end of the study afferents and motor neurons were retrogradely labelled with CtB injections into the ulnar nerve bilaterally; tissues and blood were collected for histology and ELISA, respectively, after four days. In order to maximise the level of NT3 available to the sensorimotor circuitry below the level of the injury the majority of forearm muscles were injected in the dominant limb ( Figure 2B ). An injection protocol was devised which targeted the motor end plate regions 70 . Since three-dimensional imaging has revealed motor plates can lie deep within the muscle 71 NT3 treatment was unable to correct hyperreflexia in distal forelimb circuitry. To measure hyperreflexia after injury, H reflex recordings were performed on both injected and noninjected forelimbs before surgery and then every two weeks in the NT3 and PBS group and every four weeks in naives. Previously it has been shown that stimulating the ulnar nerve at a frequency of 5 Hz during paired pulses is sufficient to induce rate dependent depression in the ADM muscle 57 . It was thought that stimulating the nerves at the wrist with a train of stimuli at 5Hz frequency would drive as much depression of the H wave as possible ( Figure 3A ). This technique has been used previously in the rodent forelimb after spinal cord injury 68 . Stimulating the wrist at 1.2x motor threshold intensity with this frequency and recording In the injected limb there was loss of rate dependent depression following injury when compared to the naïve group ( Figure 5A ). This difference between naïve and injured animals indicates the formation of hyperreflexia. There was no difference in hyperreflexia in the NT3 group compared to the PBS group, and once the hyperreflexia developed it remained constant. Hyperreflexia also developed in the noninjected limb of both injured groups compared to naïve animals ( Figure 5B ). Inclusive of all three groups there was an effect of time in the noninjected limb, indicating that hyperreflexia did increase over time. There was no interaction between group and time in either limb. Since the NT3 treatment was only injected into the previously dominant forelimb this created an internal control to assess treatment effects within each animal. Overall there was no difference in the hyperreflexia in the injected over the noninjected limb of NT3 treated animals when compared to PBS treated animals, which should in theory have remained equal in both limbs ( Figure 5C ). At baseline the motor threshold of the injected ADM (the stimulus required to generate a motor response) was consistent amongst all three groups ( Figure 5D ). The motor thresholds were comparable between both injured groups and naive animals overall, however there was a main effect of time indicating a general reduction in the motor thresholds as the study progressed. Due to the presence of bleeding from the recording site, a few individual recordings of the reflex recordings and associated motor thresholds were excluded. These are indicated by red dots in Figure 5D . There was a shift in the latency of the H wave during 6 th to 20 th stimulus at 5Hz stimulation compared to 0.2Hz stimulation ( Figure 6 ). By measuring the time taken for the following parameters of the H wave to occur; end of stimulus artefact, H wave onset and H wave offset, it was possible to measure both the latency of the H wave and the duration ( Figure 6A ). In both injured and intact animals the latency of the H wave increased during the 5Hz stimulation ( Figure 6B ). After injury the duration of the H wave remained comparable during 0.2Hz and 5Hz stimulation, however there was a decrease in duration in naives ( Figure 6C ). This was primarily because these animals had intact rate dependent depression and the H wave was barely measurable. There was no change in the offset of the H wave at either frequency ( Figure 6D ). Forelimb sensorimotor function following contusion injury was slightly greater in rats treated with NT3 Initially animals were observed during locomotion in an open field each week to assess their recovery after injury, and later to identify any muscle spasms during free movement. Throughout this task and during other the other behavioural assessments below, there was no obvious muscle spasms in either forelimbs or hindlimbs nor any obvious signs of spasticity related gait disturbances as previously reported after bilateral pyramidotomy 57 . Locomotion across an irregular horizonal ladder tests the sensorimotor function of both forelimbs. All paw placements were scored according to a detailed seven point scale that differentiates between slip based and corrective based stepping errors 67 . A full description of this scale is contained in the methods section but briefly; scores of two and below indicate slips, scores above three represent replacement steps and errors with paw placement, and finally a score of six indicate an error free step. Whilst animals were able to remain upright and locomote minimally around the home cage within one week of SCI, all animals were unable to make any weight supported steps on the horizontal ladder and were not formally assessed at this time point. Within two weeks animals began to traverse the ladder. Footage of this task was analysed after the ELISA results revealed that only three animals had raised NT3 serum levels and NT3 in the biceps was varied. Given this it was decided to only analyse the final time point at 12 weeks post injury, when any sustained benefit of NT3 would be apparent, with treatment effects identified by comparing to naïve animals. Blinding was maintained as during analysis only the individual animal numbers were used and these were not related back to treatment administered until all scores were collected. There was a significant increase in the number of slip based errors 12 weeks post injury when compared to compared to naïve controls ( Figure 7A ). The errors occurred for both injected and noninjected forelimbs and indicates that SCI did induce a bilateral deficit in forelimb placement and locomotion across a horizontal ladder chronically. NT3 treatment did not reduce this deficit compared to the PBS group. There was also no improvement in the injected compared to the noninjected forelimb in the NT3 group. Regarding the total number of erroneous steps after injury, there was evidence that SCI caused a sustained deficit as shown by the PBS group compared to naïve ( Figure 7B ). There was no difference between the NT3 and PBS groups in the number of steps taken. SCI resulted in more steps by both injected and noninjected limbs required to cross the ladder ( Figure 7C) . A full analysis of each type of error is provided in (Figure 8 ). Most noticeably, NT3 treatment was able to reduce the number of minor slips compared to PBS ( Figure 8C ), whilst increasing the proportion of steps that needed correction during placement, a score of four ( Figure 8E ). This could indicate a beneficial effect of NT3 whereby improved sensorimotor connections might prevent the number of minor slips but these steps are not error free and require corrective movements in order to maintain locomotion. Success at the single pellet reaching task requires fine sensorimotor function and proprioception to carry out the reaching, grasping and finally retrieval of small sugar pellets. In order to prevent the compensatory movement of dragging of pellets instead of grasping with the impaired forepaw, a custom device was made with a gap which separated the ledge where the pellet is presented from the reaching window ( Figure 9A ). At baseline all animals had achieved a similar ability to grasp pellets with one or more attempts ( Figure 9B ). Animals below 55 percent success rate at baseline, regardless of the number of attempts, were not included in the study. Whilst most injured animals were able to reach for pellets, three animals (n=1 for NT3 and n=2 for PBS) were excluded from the post injury analysis due to being unable to make any on target reach attempts, i.e., making contact with the pellet, at any timepoint after injury. There was a similar deficit after injury in the number of pellets that were successfully grasped and retrieved following more than one attempt. Again, the NT3 and PBS groups did not differ overall and both had significantly reduced performance compared to naïves. A main effect of time was present, indicating that on average animals retrieved a higher number of pellets requiring multiple reach attempts as the study progressed. Taking both injured groups and naives into consideration, there was a significant increase in performance between two weeks and four weeks, however performance at subsequent time points remained comparable to week 4. As before, there was no interaction between the group and time post injury and as a result, no treatment effect for NT3. Animals were perfused at 14 weeks after injury and the medial head of the biceps brachii of the injected forelimb, as well as blood, were taken to assess level of NT3 protein in these tissues. NT3 levels were expressed as a proportion of total protein present in the tissue to account for differences in protein extraction. in NT3 protein within the muscle by 14 wpi (Figure 11A ). On average AAV-NT3 increased NT3 protein levels approximately 1600 fold from levels seen in PBS treated animals and naives. SCI plus PBS injection did not alter the amount of NT3, which was comparable to levels in naives. One animal which was injected with AAV-NT3 had a much lower NT3 level of 128.6 pg/mg in the medial head, which was 50 fold lower than the average for the group. In general, AAV-NT3 did not consistently raise serum levels throughout the cohort ( Figure 11B ). Only three animals had raised NT3 levels which corresponded to a fold increase of 1.5x, 16 .5x and 44x above the average level in uninjured animals. The rest of the AAV-NT3 treated animals had levels in a similar range of untreated animals and therefore AAV-NT3 was unable to generate a significant increase in serum levels across the whole cohort. Unexpectedly, overall the levels in serum did not correlate with levels in the bicep muscle ( Figure 11C ). The two animals which had the lowest amounts of NT3 in the biceps brachii muscle had the highest elevation in serum levels. It should be noted that only a single head of the biceps brachii was analysed, and many additional muscles were also injected which may explain this difference. Explanations as to why serum levels were not raised in all animals are explored in the Discussion. Ex vivo MRI reveals disruption of white matter tracts and cavity formation. Figure 13C ). Taking the whole lesion into account there was no difference in the volume of cavitation between groups. Total cavity volume was comparable between groups. When looking at the extent of the lesion in either the rostral or caudal direction from the epicentre, cavitation extended less rostrally in NT3 treated animals compared to PBS treated animals ( Figure 13D ). The extent of the cavity caudally to the injury was comparable ( Figure 13D ). Both groups displayed lesions of comparable size ( Figure 13C ). This corroborates the fact that there was no difference between displacement of spinal cord or the force of the impact between the two groups ( Figure 14A & B) . In both injured groups there was no strong evidence of a correlation between the displacement of the spinal cord during contusion and spared white matter at the epicentre (Figure 13 C) (n.b., variation in displacement was very small). The epicentre from each animal and the automatically generated mask used to calculate presumed spared white matter is presented in Figure 15 . Effects of NT3 on afferent input reorganisation. Proprioceptive afferent terminals connect directly onto α-motor neurons through glutamatergic excitatory synapses. These connections are the primary source of vGlut1+ input directly onto motor neurons with contributions from Golgi tendon afferents and CST considered negligible in rodents 72 . To quantify these connections the motor neurons innervating the ulnar aspect of the distal forelimb were retrogradely traced with Cholera Toxin beta subunit (CTb) and vGluT+ signal in close apposition to CTb+ motor neurons were quantified ( Figure 16 A-C) . The mature neuron marker NeuN was used to both accurately delineate the soma and to distinguish α-motor neurons from γ-motor neurons 73 . Successfully traced motor neurons followed a similar size distribution in all three groups ( Figure 16D ), and had an average soma size similar to previous reports of α-motor neurons 73 . Individual vGluT1+ boutons that were distinguishable from one another and in close proximity to the soma were counted. There was no change in the average number of vGluT1+ appositions between all three groups, suggesting no afferent sprouting occurred in these animals in response to injury. Because the varying size of vGlut1+ immunoreactive puncta seen on the motor neuron perimeter suggested the possibility of two or more puncta not being distinguishable from one another, an additional method of quantification was performed . The raw integrated vGlut1+ pixel density was measured in a band 3μm thick surrounding the soma (Figure 16D ), and was achieved by allocating an intensity to each pixel on a scale of 0-255, with 0=black/no signal and 255 = maximum brightness, and calculating the sum of all pixel intensities. This was normalised to the area of the region of interest and provides a complementary approach to quantifying the amount of vGlut1+ signal irrespective of number of puncta. There was no alteration in normalised raw integrated vGlut1+ pixel density following injury, shown in the PBS group compared to naives ( Figure 16E ). NT3 treatment also had no effect on integrated vGlut1+ pixel intensity when compared to either PBS or naïve. These results suggest that afferent input was not increased to these motor neurons following injury. Despite no significant changes between groups in either analysis, both methods revealed higher absolute puncta count or pixel density in the PBS treated animals compared to both NT3 and naïve group. This could be suggestive of injury induced afferent sprouting, however this analysis was only performed on a subset of animals prior to campus lockdown for COVID in 2020. Using the data collected for Figure 16G , if this magnitude of a difference did exist in real life it is calculated that a sample size of 18 per group would be required to detect a difference with p<0.05 and 80% power. This sample size exceeds the number of rats which remained in the study. the results suggests that the dose and delivery route of AAV-NT3 used was potentially beneficial to sensorimotor forelimb function but that these functional benefits were subtle and do not correlate with a reduction in hyperreflexia. They also suggest that NT3 as a monotherapy is unable to match its therapeutic effect following pyramidotomy 57 , and as such is not able to overcome the additional damage to numerous motor pathways and grey matter populations caused by a contusion injury. Ex vivo imaging suggested that motor pathways other than the CST are spared after spinal cord injury Contusive SCI lesions can be variable and reconstructing the lesion in therapeutic studies is essential to rule out the possibility of differing lesions between groups influencing outcomes. During processing for conventional histology, the delicate tissue around the lesion site can be affected from serial sectioning which can compress and deform the tissue. To avoid this, ex vivo MRI was used to generate T2 weighted scans with high resolution from which lesion size parameters like cavity volume can be automatically measured. Quantification of experimental SCI using MRI has been used previously and shown to adequately correlate with results generated using conventional histology [74] [75] [76] . This study builds on previous analytical approaches involving manual quantification, by using an automated method to delineate the signals of interest such as hypointensities thought to correspond to cavitation and signal that is continuous with spared white matter at the extremities. This avoids variation that arises from selecting regions of interest manually and allows for a quicker quantification. Importantly, tissue can be processed later for routine immunohistochemistry, as performed in this study, without loss of antigenicity. Ex vivo MRI of the lesion generated by a 225kdyn contusion revealed damage to several white matter tracts consistent with conventional histological findings 77, 78 . Whilst individual white matter funiculi within the epicentre were not quantified, the dorsal white matter appears visually to be mostly disrupted whilst damage to the lateral and ventral white matter appears relatively spared . As a result it can be assumed that pathways associated with motor function located in these regions may have been partly spared. The CST, conveying motor signals involved with fine motor movement, is split into three distinct portions descending in the dorsal, lateral and medial-ventral funiculi. A comprehensive study involving a 250 kDyn injury to the same cervical region showed that the dorsal column projections are mostly damaged following a bilateral contusion but some ventral and dorsal-lateral CST fibres remain continuous through the lesion site 79 . As ex vivo MRI showed a lack of putative spared white matter in the dorsal columns but some in the ventral and lateral white matter, loss of the dorsal CST with some sparing of ventral and dorsal lateral CST can be expected in this study. The reticulospinal tract (ReST) arises in the reticular formation in the brain stem and descends the spinal cord in the ventral and ventrolateral funiculus in rodents 80 . Given the regions of putative sparing, it can be assumed that some sparing of reticulospinal fibres has occurred. Propriospinal neurons are thought to be mostly intact after bilateral contusion injuries as they are uniformly distributed throughout the spinal cord lateral and ventral white matter 81, 82 . The rubrospinal tract, which is essential for the arpeggio movement during reaching, was also partially spared as it descends in the dorsal lateral white matter 83 . Following injury the rubrospinal fibres reorganise by expanding their innervation of the forelimb motor pool, from predominantly distal muscles to include those of more proximally located muscles 84 shown that intramuscular AAV-NT3 normalises the excitability of H reflexes following pyramidotomy from four weeks after treatment 57 . Whilst it was not possible to verify these injections elevated NT3 in the ADM muscle, given its small size, it was assumed that it did based on the elevation found in another treated muscle, the Biceps Brachii. The ADM muscle, from which the H reflex was recorded, was injected with an equivalent dose totalling 3x10 9 GC of AAV-NT3 in both studies. This was however achieved through different means; a single injection of 10μl in the pyramidotomy study compared to two 5μl injections in the present study. Another difference was the injection of a further 3x10 9 GC of AAV-NT3 into the paw pad in the former study which was not performed here. It could be that diffusion of the viral vector throughout the paw contributed to higher titres within the ADM, or that treatment of these additional muscles, and their Ia afferents, contributes to the overall reduction of hyperreflexia. A predominance for spasms in the forelimb flexors following pyramidotomy justified the decision in that study to treat only the flexors of the elbow and wrist. This is an important difference from the present study which, in the absence of any noticeable spasms during locomotion, treated both flexors and extensors as this was decided the best chance of restoring forelimb function. A consequence of this would be additional Ia afferents from forelimb extensors, such as triceps Brachii, being exposed and modulated by NT3. Whilst the H reflex incorporates a monosynaptic connection between Ia afferent and a homonymous motor neuron, it is in reality much more complex. Motor neurons also receive monosynaptic input from afferents originating in synergistic muscles termed heteronymous connections, for example between extrinsic wrist flexors and the motor neurons innervating muscles within the paw like the ADM 93 . In addition afferents from antagonistic muscles form polysynaptic connections, via Ia afferent inhibitory interneurons, onto α-motor neurons 94 . Hyperreflexia is likely to be caused by the sum of all input, from both homonymous and heteronymous muscles, converging on the motor neuron pool of the ADM muscle directly or via interneurons. Given that extensor muscles as well as flexors were treated with AAV-NT3 in this study, it is possible that the modulation of afferent input from extensors muscle counteracts any normalisation of hyperreflexia with treatment to flexor muscles. There are several proposed mechanisms by which hyperreflexia arise such as; changes to chloride homeostasis, imbalance of excitatory and inhibitory signals converging on motor circuitry, alterations in dendritic arbours and innate increases in motor neuron excitability 17, 25, 26, 57, 95, 96 . NT3 has been shown to modulate a number of these through a mix of in vivo and in vitro studies, which may not have occurred in this study and enabled persistent hyperreflexia. NT3 can modulating dendritic branching and soma size of cortical and spinal neurons 47, 97 . Such changes would alter electrophysiological properties of the cells to reduce the chance of depolarisation and reduce intrinsic excitability of the motor neuron. These properties have been detected in spinal motor neurons undergo following intramuscular AAV-NT3 98 . It is not possible to determine the excitability of the motor pool itself through H reflex testing 19 . Motor threshold, an indication of motor axon excitability, can however reflect motor neuron excitability after SCI 99, 100 . In this study there was no difference between groups in the intensity of stimulation needed to induce a motor axon response in the ADM muscle, although over time there was a gradual decrease in all three groups. This is likely caused by technical refinements made over time, such as less repositioning of the recording electrode which would reduce bleeding. Accordingly, we conclude there is no evidence for either SCI or NT3 treatment altering the excitability of motor axons, however additional electrophysiology would need to be performed to confirm this such as threshold tracking 19, 101 or measuring of persistent inward currents 96 . Proprioceptive input onto motor neurons is glutamatergic and is essential for spontaneous motor recovery following SCI 6, 72 . After bilateral CST lesions this input is increased, due to sprouting of the centrally projecting terminals of proprioceptive afferent fibres 5 [104] [105] [106] . vGlut2 is present up to ten times more puncta per length of motor neuron membrane compared to vglut1 and is particularly abundant in the ventral horn after chronic staggered hemisection 103, 107 . As of yet alterations in vGlut2 has not been explored in relation to hyperreflexia, however optogenetic activation of vGlut2+ interneurons can initiate tail spasms in a sacral preparation 108 . Another possibility would be to extends analysis to include dendrites in addition to motor neurons. Proximal dendrites are the site of numerous vGlut1 synapses 109 and excitatory input into even distal portion of the dendritic arbour can generate excitatory post synaptic potentials in the soma 110 . Could central and peripherally acting effects of NT3 restore white matter? An unexpected result from ex vivo MRI was the discovery of more putative white matter close to the epicentre in NT3 treated animals. This occurred despite no difference between the severity of injury given to each group. In order to automatically detect putative spared white matter the software takes the T2 weighted signal within a user-defined seed region, and then expands it to incorporate similar signal. As this seed region was one lateral funiculus 2.5mm rostral to the lesion an assumption was made that the white matter in this funiculus was spared. Whilst scar tissue surrounds the cavity and is likely represented by the hyperintense signal lining the cavity, it cannot be ruled out that this signal allocated as presumptive spared white matter may also incorporate scar or oedematous tissue or other pathology. A variety of possible explanations for NT3 mediated effects on white matter after injury are discussed below and include neuroprotection, axonal regeneration and remyelination. There is also chance this increase in putative spared white matter is a false positive, since these mechanisms might be expected to act equally throughout the lesion. Whilst a neuroprotective effect of NT3 has been observed on axotomized motor neurons in neonatal rats 111 , there was no increase in survival of adult corticospinal neurons following internal capsule lesion 112 or dorsal column injury 37 . Cell loss of other neuronal populations, such as projection sensory fibres, may be prevented after NT3 is infused into the cavity after transection 113 . Whilst from a technical perspective it would be interesting to see whether ex vivo T2W MRI is sensitive enough to detect a neuroprotective effect, such an effect is unlikely to occur in this study given the different injury mechanism and the 24h-delay between contusion and onset of treatment usingNT3. One caveat to any neuroprotective role of AAV-NT3 delivered intramuscularly would be the delay from treatment at 24 hours post injury to raised NT3 in the lesion environment, which is likely to peak after apoptosis in the neuronal population peaks around 3 days 114, 115 . Modulation of the immune response acutely after injury can halt the progressive secondary pathology resulting in reduced lesion sizes and improved functional outcome. There is modest evidence suggesting that NT3 can modulate the response of immune cells 116 . Whilst serum NT3 levels were not elevated chronically, see below, there is the chance that a minimal increase in NT3 occurred after treatment and this is sufficient to affect the immune response. Blood-spinal cord barrier breakdown would be enhanced within the epicentre and access of NT3 to these zones may explain the spatially restricted increased in presumptive spared white mater in this region. Another possibility is NT3 mediated signalling modulating axon regeneration and remyelination following injury. In addition to the effects of sprouting motor pathways previously mentioned, spinally applied NT3 is able to promote the growth of sensory axons after injury 117, 118 , however regeneration following SCI is limited after treatment with a single growth factor and unlikely to be to such an extent that lesion cavity is impacted. Regarding remyelination, oligodendrocytes express TrkC and exhibit both enhanced survival in culture and upregulation of myelin associated genes following NT3 application [119] [120] [121] . A number of studies have shown beneficial effects of NT3 on remyelination following spinal cord injury 59 , such as increased myelination of regenerating neurons elongating into NT3 secreting fibroblast grafts 122 . NT3 can also encourage migration of Schwann cells 123 , which infiltrate from the periphery after SCI and contribute to remyelination 124, 125 . Conversely, a recent study found no effect of NT3 as a monotherapy on myelination of regenerating axons after hemisection, however when combined with interleukin-10 was were modest effects 59 . Recent studies have indicated that oligodendrocyte mediated remyelination plays no role in the recovery of hindlimb function following injury 126 although Schwann cell myelination may do 127 . Slow release of NT3 from chitosan grafts appears to stimulate endogenous neurogenesis after a full transection which was associated with tissue bridges spanning the 5mm injury site, restoration of sensory and motor evoked potentials and functional hindlimb recovery 128, 129 . Importantly, most aspects of this study have been independently repeated and the results replicated 130 . In summary, delayed treatment with AAV-NT3 may increase the amount of white matter near the lesion. Additional experiments would be required to identify the mechanism by which this occurs. Minimal elevation of NT3 in serum could indicate suboptimal expression of NT3 in muscle Disappointingly, serum levels of NT3 were not elevated throughout all of the NT3 group. One rationale for NT3 driven recovery is through uptake by Ia afferents and/or motor neurons innervating muscle, which is maximised with high expression of NT3 within the muscle. Whilst elevation in the serum was not the primary target it is an unexpected result as previous studies using intramuscular delivery of NT3 result in serum levels consistently elevated at similar chronic time points 57 . This discrepancy could reflect that maximal intramuscular expression of NT3 was not achieved in some animals, or the presence of other variables which limited its elevation above basal levels. Our therapy is packaged in AAV serotype 1. This serotype exhibits a high tropism for muscle, estimated 10-100 times more than other serotypes 131 and is efficient at elevating serum levels following intramuscular delivery compared to AAV2-5 132 . Testament to this is its current use in a phase I/IIa trial for Charcot-Marie-Tooth Ia neuropathy where muscle transduction is essential (NCT03520751) 133 . In the present study evidence of the high tropism for muscle, and potency of the CMV promoter used, is the 1500-fold increase in expression of NT3 in the Biceps Brachii. As with other neurotrophins, NT3 is quickly eliminated from circulation with a half-life in plasma in the magnitude of minutes 46, 134 . Following chronic infusion from subcutaneous osmotic pumps of NGF, another member of the neurotrophin family with a similar half-life in serum, the elimination half-life can be extended 135 . Despite this, full elimination occurs within 24 hour and is suspected to be a similar time course for NT3. It is clear that for elevation to be sustained in serum long term, NT3 must be continually secreted and at a rate which surpasses the amount which is efficiently cleared. For NT3 synthesised in muscle to be released into the circulation it must undergo extracellular secretion, diffusion through extracellular matrix surrounding myofibrils and finally pass through the endothelial wall. The endothelial monolayer is permeable to molecules with a molecular weight of up to 100kDa 136 , much larger than NT3 at approximately 14kDa. No studies have explicitly looked at vascular permeability of NT3 but it is able to cross the tightly regulated blood brain barrier at a low rate 134 ,and presumably also able to at muscle capillaries. Capillary density varies massively depending of both muscle fibre type 137 and size This was the first study in which intramuscular AAV-NT3 was used in an attempt to treat forelimb sensorimotor deficits after bilateral spinal cord cervical contusion. Whilst the treatment was able to successfully recover some function of forelimb involvement in locomotion, it was subtle and did not alter the sustained hyperreflexia that occurred. This limited response to NT3 is likely a result of the highly complex injury with multiple pathological processes at play which is a major challenge when attempting to test therapies to ever more clinically relevant models. It is possible that AAV-NT3, a neuroplasticity-based therapy, may benefit being part of a combinational therapeutic intervention including intensive forelimb rehabilitation to maximise afferent input after injury and ensure functionally relevant connections are sustained. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics Electromyographic activity associated with spontaneous functional recovery after spinal cord injury in rats Neuronal activity and microglial activation support corticospinal tract and proprioceptive afferent sprouting in spinal circuits after a corticospinal system lesion Selective corticospinal tract injury in the rat induces primary afferent fiber sprouting in the spinal cord and hyperreflexia Functional Local Proprioceptive Feedback Circuits Initiate and Maintain Locomotor Recovery after Spinal Cord Injury Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats Functional and anatomical reorganization of the sensory-motor cortex after incomplete spinal cord injury in adult rats Cervical sprouting of corticospinal fibers after thoracic spinal cord injury accompanies shifts in evoked motor responses Muscle spindle feedback directs locomotor recovery and circuit reorganization after spinal cord injury & Trajectories of Outcome in Neurological Conditions, s. Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions Spasticity: Disordered Motor Control Epidemiology of spasticity following traumatic spinal cord injury Spasticity after traumatic spinal cord injury: nature, severity, and location Low frequency depression of H-reflexes in humans with acute and chronic spinal-cord injury Exercise modulates chloride homeostasis after spinal cord injury Modulation of soleus stretch reflexes during walking in people with chronic incomplete spinal cord injury The H-reflex as a probe: pathways and pitfalls The hoffmann reflex: methodologic considerations and applications for use in sports medicine and athletic training research Suppression of the H reflex in humans by disynaptic autogenetic inhibitory pathways activated by the test volley Sensitivity of Hreflexes and stretch reflexes to presynaptic inhibition in humans Spastic movement disorder: impaired reflex function and altered muscle mechanics Imbalanced Corticospinal and Reticulospinal Contributions to Spasticity in Humans with Spinal Cord Injury Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury Role of persistent sodium and calcium currents in motoneuron firing and spasticity in chronic spinal rats Down-regulation of KCC2 expression and phosphorylation in motoneurons, and increases the number of in primary afferent projections to motoneurons in mice with post-stroke spasticity Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury A Review of Spasticity Treatments: Pharmacological and Interventional Approaches Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases Neurotrophin-3 Sorts to the Constitutive Secretory Pathway of Hippocampal Neurons and Is Diverted to the Regulated Secretory Pathway by Coexpression with Brain-Derived Neurotrophic Factor Proneurotrophin-3 promotes cell cycle withdrawal of developing cerebellar granule cell progenitors via the p75 neurotrophin receptor Proneurotrophin-3 is a neuronal apoptotic ligand: evidence for retrograde-directed cell killing Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferents Muscle spindle-derived neurotrophin 3 regulates synaptic connectivity between muscle sensory and motor neurons NT-3 increases amplitude of EPSPs produced by axotomized group Ia afferents Local and remote growth factor effects after primate spinal cord injury trkC-like immunoreactivity in the primate descending serotonergic system Neurotrophins: roles in neuronal development and function The p75 neurotrophin receptor is essential for neuronal cell survival and improvement of functional recovery after spinal cord injury Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons Neuropeptides and neurotrophin receptor mRNAs in primary sensory neurons of aged rats Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesions Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord Stroke Recovery in Rats after 24-Hour-Delayed Intramuscular Neurotrophin-3 Infusion Remodeling of lumbar motor circuitry remote to a thoracic spinal cord injury promotes locomotor recovery Descending motor circuitry required for NT-3 mediated locomotor recovery after spinal cord injury in mice Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord Either brain-derived neurotrophic factor or neurotrophin-3 only neurotrophin-producing grafts promote locomotor recovery in untrained spinalized cats Vector-induced NT-3 expression in rats promotes collateral growth of injured corticospinal tract axons far rostral to a spinal cord injury Voluntary exercise increases neurotrophin-3 and its receptor TrkC in the spinal cord Activity-dependent increase in neurotrophic factors is associated with an enhanced modulation of spinal reflexes after spinal cord injury Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle Reticulospinal plasticity after cervical spinal cord injury in the rat involves withdrawal of projections below the injury Intramuscular Neurotrophin-3 normalizes low threshold spinal reflexes, reduces spasms and improves mobility after bilateral corticospinal tract injury in rats Muscle injection of AAV-NT3 promotes anatomical reorganization of CST axons and improves behavioral outcome following SCI Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model Targeting recovery: priorities of the spinal cord-injured population Pilot clinical trial of NT-3 in CMT1A patients RNAseq dataset describing transcriptional changes in cervical sensory ganglia after bilateral pyramidotomy and forelimb intramuscular gene therapy with AAV1 encoding human neurotrophin-3 Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies Three-dimensional imaging of microvasculature in the rat spinal cord following injury The ladder rung walking task: a scoring system and its practical application Plasticity in ascending long propriospinal and descending supraspinal pathways in chronic cervical spinal cord injured rats Analysis of longitudinal data from animals with missing values using SPSS Spatial characterization of the motor neuron columns supplying the rat forelimb Spatial Distribution of Motor Endplates and its Adaptive Change in Skeletal Muscle Permanent central synaptic disconnection of proprioceptors after nerve injury and regeneration. I. Loss of VGLUT1/IA synapses on motoneurons Gamma and alpha motor neurons distinguished by expression of transcription factor Err3 Magnetic resonance imaging versus histological assessment for estimation of lesion volume after experimental spinal cord injury. Laboratory investigation Neuropathological differences between rats and mice after spinal cord injury Longitudinal Comparison of Two Severities of Unilateral Cervical Spinal Cord Injury Using Magnetic Resonance Imaging in Rats Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages Differential Histopathological and Behavioral Outcomes Eight Weeks after Rat Spinal Cord Injury by Contusion, Dislocation, and Distraction Mechanisms Bilateral cervical contusion spinal cord injury in rats Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord Anatomical and Molecular Properties of Long Descending Propriospinal Neurons in Mice Retrogradely Transportable Lentivirus Tracers for Mapping Spinal Cord Locomotor Circuits Impaired arpeggio movement in skilled reaching by rubrospinal tract lesions in the rat: a behavioral/anatomical fractionation Reorganization of descending motor tracts in the rat spinal cord Cortico-reticulo-spinal circuit reorganization enables functional recovery after severe spinal cord contusion Bridging the gap: a reticulo-propriospinal detour bypassing an incomplete spinal cord injury The role of propriospinal interneurons in recovery from spinal cord injury Integration in descending motor pathways controlling the forelimb in the cat. 11. Inhibitory pathways from higher motor centres and forelimb afferents to C3-C4 propriospinal neurones Dexterous finger movements in primate without monosynaptic corticomotoneuronal excitation RNA sequencing dataset describing transcriptional changes in cervical dorsal root ganglia after bilateral pyramidotomy and forelimb intramuscular gene therapy with an adeno-associated viral vector encoding human neurotrophin-3 Permeability of the blood-brain barrier to neurotrophins Role of motoneuron-derived neurotrophin 3 in survival and axonal projection of sensory neurons during neural circuit formation Pattern of monosynaptic Ia connections in the cat forelimb Spinal Control of Locomotion: Individual Neurons, Their Circuits and Functions Dendritic spine dysgenesis contributes to hyperreflexia after spinal cord injury Spastic long-lasting reflexes in the awake rat after sacral spinal cord injury Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth Skin incision induces expression of axonal regeneration-related genes in adult rat spinal sensory neurons Axonal changes in spinal cord injured patients distal to the site of injury Plasticity of lower limb motor axons after cervical cord injury Excitability of human axons Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury Undirected compensatory plasticity contributes to neuronal dysfunction after severe spinal cord injury Vesicular glutamate transporters in the spinal cord, with special reference to sensory primary afferent synapses Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia Neurotransmitter phenotypes of descending systems in the rat lumbar spinal cord Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular Atrophy Sacral Spinal Cord Transection and Isolated Sacral Cord Preparation to Study Chronic Spinal Cord Injury in Adult Mice Normal distribution of VGLUT1 synapses on spinal motoneuron dendrites and their reorganization after nerve injury Somatic EPSP amplitude is independent of synapse location in hippocampal pyramidal neurons Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats but not NT-3, promotes long-term survival of axotomized adult rat corticospinal neurons in vivo NT-3, but not BDNF, prevents atrophy and death of axotomized spinal cord projection neurons Apoptosis in cellular compartments of rat spinal cord after severe contusion injury Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury Neurotrophins and the immune system NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord A crucial role for neurotrophin-3 in oligodendrocyte development Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes Neurotrophin-3 and brainderived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases Endogenous repair after spinal cord contusion injuries in the rat Sonic hedgehog and neurotrophin-3 increase oligodendrocyte numbers and myelination after spinal cord injury Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury NT3-chitosan elicits robust endogenous neurogenesis to enable functional recovery after spinal cord injury The effect of the dosage of NT-3/chitosan carriers on the proliferation and differentiation of neural stem cells Validation study of neurotrophin-3-releasing chitosan facilitation of neural tissue generation in the severely injured adult rat spinal cord Characterization of tissue tropism determinants of adenoassociated virus type 1 Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype Vectors NT-3 gene therapy for Charcot-Marie-Tooth neuropathy Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle Microvascular supply in relation to fiber metabolic type in mixed skeletal muscles on rabbits Fiber capillary supply related to fiber size and oxidative capacity in human and rat skeletal muscle Anatomical, architectural, and biochemical diversity of the murine forelimb muscles Capillary supply and mitochondrial content of different skeletal muscle fiber types in untrained and endurance-trained men. A histochemical and ultrastructural study This research was principally funded by a Nathalie Rose Barr PhD studentship from the Spinal Research Trust (NRB117 to LDFM for JS-S). This project was also partly funded by the Medical Research Trust (S026053/1 to LDFM). We acknowledge the Penn Vector Core in the Gene Therapy Program of the University of Pennsylvania for production of the AAVs for this project.We thank Dr Diana Cash and Dr Eugene Kim (King's College London preclinical imaging core) for their help with acquisition of magnetic resonance images. Thanks to Emily Burnside for training and advice regarding surgery. Thanks to Mohammed Ilyaas Javid for the pellet reaching boxes. Thanks to Zoe Hore for blind-coding the interventions.